Cellectis
CLLS
32 hedge funds and large institutions have $32.5M invested in Cellectis in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 14 reducing their positions, and 5 closing their positions.
4,100% more call options, than puts
Call options by funds: $42K | Put options by funds: $1K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.33% less ownership
Funds ownership: 10.51% → 10.19% (-0.33%)
6% less funds holding
Funds holding: 34 → 32 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
36% less capital invested
Capital invested by funds: $51.1M → $32.5M (-$18.6M)
79% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$62.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$51.8K |
| 3 |
Lido Advisors
Los Angeles,
California
|
+$38.7K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$6.68K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$527K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$196K |
| 3 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
-$167K |
| 4 |
BlackRock
New York
|
-$164K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$132K |
CLLS Hedge Fund Activity: Q1 2026 in Review
32 of the 8,198 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2026, worth a combined $32.5M — down 36% from $51.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CLLS and 4 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 3 added.
The largest buyer was XTX Topco, opening a new position worth an estimated $62.4K. The largest seller was Marshall Wace, cutting an estimated $527K.
- 32 institutional investors held Cellectis (CLLS) as of Q1 2026, down from 34 in Q4 2025.
- Funds reported $32.5M of Cellectis stock for Q1 2026, down 36% quarter-over-quarter.
- 4 funds opened new Cellectis positions in Q1 2026 and 5 closed out, a net change of -1 holder.
- The largest Cellectis buyer in Q1 2026 was XTX Topco, an estimated $62.4K added.
- The largest Cellectis seller in Q1 2026 was Marshall Wace, an estimated $527K sold.
Based on aggregated 13F filings for Q1 2026.